All of the SCCs showed a weakly positive expression of GPR31 (Figure 1b, Supplementary Figure S1), whereas half of the BCC samples showed a weak expression (Figure 2b), and the other half were negative for GPR31 (Supplementary Figure S2). Here, GPR31 is linked to skin basal cell carcinoma.